tyrosine has been researched along with Hematoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balla, G; Balla, J; Csonka, T; Eaton, JW; Galajda, Z; Jeney, V; Méhes, G; Nagy, E; Smith, A; Soares, MP; Szentmiklósi, J; Varga, Z; Vercellotti, GM | 1 |
| Aydin, M; Bilge, M; Gursurer, M; Ozdemir, H; Ozeren, A; Savranlar, A | 1 |
| Aoun, N; Azar, R; Kadri, Z; Moussa, R; Sarkis, A | 1 |
| Brosstad, F; Goggin, T; Lehne, G; Midtvedt, K; Nordal, KP | 1 |
| Adam, PC; Evemy, KL; Pemberton, J | 1 |
5 other study(ies) available for tyrosine and Hematoma
| Article | Year |
|---|---|
Red cells, hemoglobin, heme, iron, and atherogenesis.
Topics: Aorta; Atherosclerosis; Cell Survival; Cells, Cultured; Endothelial Cells; Erythrocytes; Glutathione; Glutathione Peroxidase; Haptoglobins; Hematoma; Heme; Heme Oxygenase-1; Hemoglobins; Hemolysis; Hemopexin; Humans; Iron; Lipid Peroxidation; Lipoproteins, LDL; Methemoglobin; Oxidation-Reduction; Oxidative Stress; Tyrosine | 2010 |
Retroperitoneal hematoma following tirofiban and enoxaparin coadministration in a patient with acute coronary syndrome.
Topics: Acute Disease; Aged; Anticoagulants; Coronary Disease; Enoxaparin; Hematoma; Humans; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Retroperitoneal Space; Tirofiban; Tyrosine | 2003 |
Cerebellar hematoma complicating 600 mg loading dose of clopidogrel in combination with tirofiban.
Topics: Aged; Cerebellar Diseases; Clopidogrel; Drug Therapy, Combination; Hematoma; Humans; Male; Ticlopidine; Tirofiban; Tyrosine | 2008 |
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction.
Topics: Acetates; Adenosine Diphosphate; Adult; Aged; Bleeding Time; Creatinine; Female; Half-Life; Hematoma; Humans; Kidney Diseases; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine | 1998 |
Exit of platelet glycoprotein-IIb/IIIa-receptor inhibitors?
Topics: Aged; Angina, Unstable; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematoma; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Streptokinase; Thrombolytic Therapy; Tirofiban; Tyrosine | 2001 |